AYVAKIT vs EVEROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. AYVAKIT and EVEROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AYVAKIT	EVEROLIMUS
Rating	New	70/100
Pharmacy pays	—	~$229.16 /30
Type	RX	RX
Active ingredient	AVAPRITINIB	EVEROLIMUS
Manufacturer	Blueprint Medicines	Biocon Pharma
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Half-life	—	about 30 hours (mean terminal elimination half-life)
Treats	Gastrointestinal Stromal Tumors	—

ayvakit everolimus

Rating

New

70/100

Pharmacy pays

—

~$229.16 /30

Type

Active ingredient

AVAPRITINIB

EVEROLIMUS

Manufacturer

Blueprint Medicines

Biocon Pharma

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Half-life

—

about 30 hours (mean terminal elimination half-life)

Treats

Gastrointestinal Stromal Tumors

—

Frequently asked questions

What is the difference between Ayvakit and Everolimus?

Ayvakit contains Avapritinib, while Everolimus contains Everolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.